Death · patients with asymptomatic, HIV‐infected, treatment naive adults
Early ART probably leads to lower death compared with standard or deferred ART (CD4 <= 200 or CD4 <= 250 cells/µl) (moderate certainty).
1 finding from 1 review
Tuberculosis · patients with asymptomatic, HIV‐infected, treatment naive adults
Early ART showed no clear difference in tuberculosis compared with standard or deferred ART (CD4 <= 200 or CD4 <= 250 cells/µl) (moderate certainty).
1 finding from 1 review
Disease progression measured by opportunistic disease Opportunistic disease events · patients with asymptomatic, HIV‐infected, treatment naive adults
Early ART showed no clear difference in disease progression measured by opportunistic disease Opportunistic… compared with standard or deferred ART (CD4 <= 200 or CD4 <= 250 cells/µl) (low certainty).
1 finding from 1 review
All‐cause mortality at 6 to 12 months · HIV‐positive people with cryptococcal meningitis
Early ART may leads to higher all‐cause mortality at 6 to 12 months compared with delayed ART initiation (low certainty).
1 finding from 1 review
Cryptococcal meningitis relapse · HIV‐positive people with cryptococcal meningitis
Early ART showed no clear difference in cryptococcal meningitis relapse compared with delayed ART initiation (low certainty).
1 finding from 1 review
Cryptococcal IRIS · HIV‐positive people with cryptococcal meningitis
It is very uncertain whether early ART changes cryptococcal IRIS compared with delayed ART initiation (very low certainty).
1 finding from 1 review
HIV virological suppression at 6 months (viral load < 400 copies/mL) · HIV‐positive people with cryptococcal meningitis
It is very uncertain whether early ART changes HIV virological suppression at 6 months (viral load < 400 copies/mL) compared with delayed ART initiation (very low certainty).
1 finding from 1 review